Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer (original) (raw)

Effects of Primary Chemotherapy on Biological Parameters of Locally Advanced Breast Cancera

Anna Passoni

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

Effects of Primary Chemotherapy on Biological Parameters of Locally Advanced Breast Cancer

Anna Passoni

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

Prognostic value of different factors in breast carcinoma

Borislav E Belev, Marijana Corić

Tumori, 2004

View PDFchevron_right

GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature

Patrizia Querzoli

Diagnostics, 2021

View PDFchevron_right

Serum Levels of Insulin-Like Growth Factor-I in Operable Breast Cancer in Relation to the Main Prognostic Variables and their Perioperative Changes in Relation to those of Prolactin

Michele Cataldo

Tumori Journal, 1994

View PDFchevron_right

AgNORs in breast tumours

Claudio Ceccarelli

Micron, 2000

View PDFchevron_right

Characterization of GATA3 and Mammaglobin in breast tumors from African American Women

Fortune Journals

View PDFchevron_right

Prognostic factors in the treatment of breast carcinoma

Valerijus Ostapenko

View PDFchevron_right

Old and new markers for breast cancer prognosis: the need for integrated research on quantitative issues

Elia Mario Biganzoli

European Journal of Cancer, 2004

View PDFchevron_right

Prognostic factors in invasive carcinoma of the breast

Sarah Pinder

Clinical Oncology, 1998

View PDFchevron_right

Mammaglobin A: A Promising Marker for Breast Cancer

Michael Duffy

Clinical Chemistry, 2002

View PDFchevron_right

Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response

Gary Whitman

Cancer, 2004

View PDFchevron_right

Immunohistochemical Analysis of Expression of GATA3 in Carcinoma Breast and its Correlation with Prognostic Parameters

Charanjeet Ahluwalia

Annals of Pathology and Laboratory Medicine, 2021

View PDFchevron_right

A Study of Prognostic Factors in Carcinoma Breast

Nadeem Nadeem

Journal of Evolution of Medical and Dental Sciences

View PDFchevron_right

Prognostic Factors in the Evaluation of Metastatic Breast Cancer

oana arghir

2008

View PDFchevron_right

The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival

fügen aker

Clinical and Translational Oncology, 2015

View PDFchevron_right

Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012

clarisa gonzalez

Tumor Biology, 2013

View PDFchevron_right

Immunohistochemical analisys in Breast Carcinoma Treated with Conservative Surgery

Diana Clenciu

Revista de Chimie

View PDFchevron_right

Prognostic Factors for Breast Cancer Recurrence after Conservative Treatment

Souha Sahraoui

2022

View PDFchevron_right

Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment

Marco Materazzo

Anticancer Research

View PDFchevron_right

Depths of Malignancy: On the Prognosis of Breast Cancer [Letter]

Anumta Ali

International Journal of General Medicine

View PDFchevron_right

Studies of biochemical parameters in breast cancer with and without metastasis

PRAVEEN SHARMA

Indian journal of clinical biochemistry : IJCB, 2004

View PDFchevron_right

Differences in GATA3 expression among histological/molecular subtypes and grades in infiltrating breast carcinoma (IBC) are important in the diagnosis of metastatic breast carcinoma

Monica Boros

Polish Journal of Pathology

View PDFchevron_right

CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer

David Slouka

Anticancer Research, 2018

View PDFchevron_right

Study of diagnostic and prognostic parameters in Breast cancer patients without metastasis

Rabail Alam

2020

View PDFchevron_right

Are mammaglobin and gcdfp-15 sensitive markers for diagnosis of metastatic basal-like triple negative breast carcinomas?

Nasser Rakhshani

Turkish Journal of Pathology, 2013

View PDFchevron_right

Long-term Prognostic Impact of Immunohistochemical Estrogen Receptor Determinations Compared with Biochemical Receptor Determination in Primary Breast Cancer

Ulf-Håkan Stenman

Acta Oncologica, 1997

View PDFchevron_right

Prognostic significance of the serum level of different growth factors and their correlation with estrogen receptors in patients with locally advanced breast cancer

Oana Tudoran

View PDFchevron_right